Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Capsule: SOP for Microbial Limit Testing for Capsules – V 2.0

Posted on By

Capsule: SOP for Microbial Limit Testing for Capsules – V 2.0

Standard Operating Procedure for Microbial Limit Testing for Capsules

Department Capsule Manufacturing
SOP No. SOP/CM/185/2025
Supersedes SOP/CM/185/2022
Page No. Page 1 of 9
Issue Date 01/02/2025
Effective Date 05/02/2025
Review Date 01/02/2026

1. Purpose

This SOP defines the procedure for conducting microbial limit testing on capsules to ensure that the product complies with microbiological standards and is safe for consumer use.

2. Scope

This SOP applies to the microbial limit testing of all capsule batches to ensure compliance with the regulatory limits for microbial contamination.

3. Responsibilities

  • Quality Control (QC) Team: Responsible for performing the microbial limit testing and ensuring that the capsules meet the defined microbiological specifications.
  • Quality Assurance (QA) Team: Ensures the test criteria and methods comply with regulatory requirements and approves the results.
  • Production Team: Provides capsule samples for microbial limit testing at the appropriate stages of production and ensures proper handling during the sampling process.

4. Accountability

The QA Manager is responsible for ensuring the microbial limit testing process complies with GMP and regulatory standards. The QC Supervisor is responsible for the proper execution of the microbial testing procedure. The Production Supervisor

ensures proper sampling of capsules for microbial testing.

See also  Capsule: SOP for Receiving Raw Materials for Capsule Manufacturing - V 2.0

5. Procedure

5.1 Pre-Testing Setup

Before initiating microbial limit testing, the following steps should be completed:

  1. Review Microbial Testing Criteria

    1. Review the microbial limits based on regulatory requirements (e.g., USP, EP). The limits must be approved by the QA department before initiating testing.
  2. Prepare Testing Equipment

    1. Ensure all microbiological testing equipment (e.g., incubators, petri dishes, sterile tools) is clean and calibrated. Document calibration in the Equipment Calibration Log (Annexure 1).
  3. Prepare Sample Collection

    1. Collect a representative sample of capsules, ensuring that the sample is randomly selected. Typically, 10-20 capsules are required for testing.

5.2 Microbial Limit Testing Procedure

Follow these steps for conducting microbial limit testing:

  1. Sample Preparation

    1. Carefully open each selected capsule and remove the fill material. Weigh the material if necessary and transfer it to a sterile container or broth for testing.
  2. Microbial Culturing

    1. Inoculate the sample with an appropriate medium to allow microbial growth. Incubate the samples at the required temperature for the specified time as per the testing standard (e.g., 37°C for 48 hours for total aerobic microbial count).
  3. Microbial Identification

    1. After incubation, examine the culture plates for microbial growth. Perform microbial identification (e.g., using Gram staining, biochemical tests) if necessary to confirm the type of contamination.
  4. Quantification of Microbial Content

    1. Count the number of colonies that have grown. Compare the microbial load with the predefined acceptance criteria (e.g., no more than 100 CFU/g for total aerobic bacteria).
  5. Document Results

    1. Record the results of microbial testing in the Microbial Limit Testing Log (Annexure 2). Document the number of colonies, any deviations, and the corrective actions taken.
See also  Capsule: SOP for Cleaning Sieves and Screens in Capsule Production - V 2.0

5.3 Post-Testing Activities

After completing microbial limit testing, ensure the following actions are performed:

  1. Review Results

    1. The QA Manager reviews the test results and ensures that the capsules comply with the defined microbial limits. If any capsules exceed the limits, initiate an investigation into the cause.
  2. Corrective Actions

    1. If microbial contamination exceeds acceptable limits, investigate the source of contamination (e.g., raw materials, environment, equipment) and implement corrective actions such as adjusting manufacturing processes or sterilization procedures.
  3. Training and Feedback

    1. If errors are identified in the process, provide feedback and additional training to the operators to ensure that the procedures are followed correctly.
  4. Record Keeping

    1. Ensure that all records related to microbial testing, including the test logs, results, and corrective actions, are archived according to regulatory and company requirements.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • QA: Quality Assurance
  • QC: Quality Control
  • CFU: Colony Forming Units
  • USP: United States Pharmacopeia
  • EP: European Pharmacopeia
See also  Capsule: SOP for Cleaning and Drying Capsule Counting Machines - V 2.0

7. Documents

  1. Annexure 1: Equipment Calibration Log
  2. Annexure 2: Microbial Limit Testing Log
  3. Annexure 3: Corrective Action Report

8. References

  • FDA Guidance on Microbial Limit Testing
  • Good Manufacturing Practice (GMP) Guidelines
  • USP <61> – Microbiological Examination of Nonsterile Products
  • EP 2.6.12 – Microbial Limit Tests

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure 1: Equipment Calibration Log

Equipment ID Calibration Date Operator Calibration Details Next Calibration Due
Incubator 502 01/02/2025 John Doe Calibration of temperature range 01/02/2026

Annexure 2: Microbial Limit Testing Log

Capsule ID Test Date Microbial Count (CFU/g) Acceptable Limit Result Remarks
Batch 001 02/02/2025 50 100 CFU/g Pass No contamination

Annexure 3: Corrective Action Report

Batch ID Deviation Corrective Action Responsible Person Completion Date
Batch 001 Excess microbial contamination Investigation and equipment cleaning Production Supervisor 03/02/2025

12. Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial version of SOP Creation of SOP for microbial limit testing QA Head
01/02/2025 2.0 Updated microbial limit testing method Refined testing process and record keeping QA Head
Capsules V 2.0 Tags:Active pharmaceutical ingredients (APIs) Capsule excipients, Capsule batch records, Capsule cleaning procedures, Capsule content uniformity, Capsule deviation management, Capsule disintegration testing, Capsule dissolution testing, Capsule filling process, Capsule inspection techniques, Capsule labeling requirements, Capsule maintenance protocols, Capsule Manufacturing, Capsule manufacturing equipment, Capsule packaging standards, Capsule process validation, Capsule production scheduling, Capsule Quality Control, Capsule regulatory compliance, Capsule safety guidelines, Capsule sealing methods, Capsule size specifications, Capsule stability testing, Capsule storage conditions, Capsule training programs, Empty capsule shells, Hard gelatin capsules, Pharmaceutical capsules, Soft gelatin capsules, Vegetarian capsules

Post navigation

Previous Post: BA-BE Studies: SOP for Filing Form 44 to CDSCO for BA/BE Studies – V 2.0
Next Post: Tablets: SOP for Reviewing In-Process Quality Control Results – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version